{
  "id": 16476398,
  "title": "Oklo chief of staff John Hanson sells $41,129 of stock",
  "url": "https://urgent.news/2026/10/25/oklo-chief-of-staff-john-hanson-sells-41-129-of-stock",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-25T12:31:09.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/insider-trading-news/oklo-chief-of-staff-john-hanson-sells-41129-of-stock-93CH-4971172"
  },
  "original_language": "en",
  "account": "Chief of Staff John Hanson of Oklo Inc. (NASDAQ: OKLO) recently sold 1,100 shares of the company's Class A Common Stock on September 28, 2026, according to a Form 4 filing with the Securities and Exchange Commission. The sale, valued at $41,129, was made to meet tax withholding obligations related to the vesting and settlement of restricted stock units (RSUs). This transaction was not a discretionary move by Mr. Hanson.\n\nAt the time of the sale, Oklo shares were trading near their 52-week low of $26.07, with the stock down approximately 81% over the past year to its current price of $26.35. Pro Research Reports suggest the stock is trading close to its Fair Value, and InvestingPro offers comprehensive analysis for investors interested in Oklo's prospects.\n\nMr. Hanson had also seen 2,059 restricted stock units vest on September 26, 2026, each representing a right to receive one share of the company's Class A Common Stock. These RSUs were granted to him on November 4, 2025. As of the reported transactions, Mr. Hanson holds 361,350 shares of the company's Class A Common Stock and 53,062 restricted stock units.\n\nRecent analyst updates on Oklo Inc. include Piper Sandler adjusting its price target to $49, down from $55, with an Overweight rating, while maintaining confidence in the company's nuclear projects. Canaccord Genuity reaffirmed a Buy rating with a $100 price target, anticipating potential revenue growth from Oklo's isotope division. Truist Securities held a more cautious Hold rating with a $51 price target, observing ongoing development across Oklo's Power, Fuel, and Isotopes segments. UBS decreased its price target to $41 from $55, citing revised estimates with higher expected expenses and adjusted EBITDA projections. These varied analyst perspectives reflect differing opinions on Oklo's financial strategies and project advancements.",
  "summary": null,
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}